Insights On Drug Development
-
Real-Time Live Cell Imaging In Successful ADC Development
1/4/2024
Learn how the visualization of critical cellular responses can enable live-cell imaging to indicate effective payload delivery, increasing the potential of identifying clinically viable ADC leads.
-
Lowering The Lipids Barrier: The Key To Accelerating RNA-LNP Drug Development
12/27/2023
Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.
-
Top 6 Questions To Ask When Evaluating A Biologics CDMO
12/15/2023
Learn how a CDMO with a commitment to quality and decades of industry experience can help overcome development hurdles and bring your treatment to patients in need.
-
5 New Questions To Ask Before Signing With A Biologics CDMO
12/15/2023
Outsourcing is now a true collaboration in which innovators and CDMOs co-create the future of medicine. Explore how the right CDMO can help sponsors unlock the full potential of their biotherapeutics.
-
Optimization-By-Design - A Critical Factor In Viral Vector Scale Up
12/14/2023
Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.
-
The Bioanalytical Development Journey
12/14/2023
Learn how a CDMO with the capability to develop assays to support a wide range of drug substances can support your journey from discovery to clinical manufacturing with reduced cost and time.
-
Vial Breakage During Lyophilization: Root Causes And Mitigation
12/12/2023
Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.
-
Following The Science To Develop Best-In-Class Cancer Drugs
12/11/2023
As innovative cancer therapeutics continue to enter the clinical trial pipeline, some developers are shifting their focus towards developing drugs that are safe and efficacious with minimal toxicity.
-
A Lean, Agile Business Model To Deliver High-Quality Oncologic Treatments
12/11/2023
No two journeys through the drug pipeline are the same; the ability to leverage a variety of approaches for different products is what sets one lean biotech company apart.
-
A Tale Of Two Brothers: The Abpro Founders
12/11/2023
By founding their latest venture, Abpro, Ian and Eugene Chan are using their synergistic skillsets in business and medicine to rapidly generate antibodies that treat cancer and autoimmune diseases.